---
title: "Notes: masterclasses and regulatory notes | Take Friday Off"
description: "Masterclasses with the people who built Australia’s natural health industry, TGA regulatory notes and product development lessons from Take Friday Off."
url: https://takefridayoff.com/notes
updated: 2026-10-22
---
# Notes

Masterclasses with industry builders and regulatory notes.

- [GMP clearance in 2026: the extensions, the three-year rule and the new portal](https://takefridayoff.com/notes/gmp-clearance-2026) (2026): Since mid-2025 the TGA has extended thousands of overseas GMP clearances without an application, gone back to a three-year limit on the inspection evidence it accepts, worked its queue down and put PIC/S version 17 into force. What it means for a supplement made overseas.
- [The Advertising Code in 2026: TGO 116, a consultation and enforcement](https://takefridayoff.com/notes/advertising-code-2026) (2026): The Therapeutic Goods Advertising Code now points to TGO 116, the TGA consulted on changes to it from July to September, and it gave over 75 infringement notices in the second half of 2025, mostly for alleged unlawful advertising. What changed, and what it means for a supplement brand's marketing.
- [Permissible Ingredients: the third determination of 2026 and the andrographis removal](https://takefridayoff.com/notes/permissible-ingredients-october-2026) (2026): The TGA's list of ingredients a listed medicine can use changed twice in a month: andrographis came off on 17 September, and the third determination of 2026 commenced on 16 October with five new ingredients. What changed, and what it means for a formula in development.
- [TGO 116 has replaced TGO 92: what changes for supplement labels](https://takefridayoff.com/notes/tgo-116-replaces-tgo-92) (2026): TGO 92 was repealed on 30 September 2026 and TGO 116 is now the labelling order for listed medicines. What changed, what the transition to 2031 allows, and what to do with a label you are designing now.
- [Masterclass: Jeremy Hunt](https://takefridayoff.com/notes/masterclass-jeremy-hunt) (2021): Are the days of limitless CBEC and Daigou growth gone? Jeremy Hunt, Chief Executive of The Common Good Company and part of the Swisse team that opened China, on where the model is heading.
- [Masterclass: Peter Schwarzer, Ingredients Plus](https://takefridayoff.com/notes/masterclass-peter-schwarzer-ingredients-plus) (2021): Raw materials are over 70% of COGS and drive most of your claims, labels and marketing. A conversation about seed-to-source supply chains, adulteration, forecasting and the rule of seven.
- [New ingredient listing rules may impact innovative raw-material suppliers](https://takefridayoff.com/notes/new-ingredient-listing-rules-may-impact-innovative-raw-material-suppliers) (2021): Proprietary Ingredients have long protected trade-secret manufacturing processes by disclosing them only to the TGA. Changes to how ingredients are listed put that commercial tool under pressure.
- [Masterclass: Evan Hayes, Factors Group](https://takefridayoff.com/notes/masterclass-evan-hayes-factors-group) (2021): Vertical integration from farm to finished product, B Corp, 97-ingredient formulas, first-mover advantage and what keeps one of Australia's most successful natural product developers up at night.
- [Sharing our four-pronged approach to TGA's requirements with NutraIngredients Asia](https://takefridayoff.com/notes/sharing-our-four-pronged-approach-to-tgas-requirements-with-nutraingredients-asia) (2020): Permitted Indications and TGO 92 changed how listed medicines make claims. Our four steps for sponsors: update the evidence, select permitted indications, update the label, verify the label against the ARTG.
